Vaccine envy: Why can't Canada make COVID-19 doses at home? - News Summed Up

Vaccine envy: Why can't Canada make COVID-19 doses at home?


CBC News has received hundreds of emails and comments from readers about vaccine production in recent weeks. In February, the government announced a partnership with the Maryland-based company Novavax to produce its promising COVID-19 vaccine at this government-owned plant. The federal government is spending $173 million to help Quebec City-based Medicago develop a COVID-19 vaccine and build a large plant to produce it. Unlike the other COVID-19 vaccines that have been authorized for use, Medicago's vaccine uses virus-like particles which mimic the structure of the coronavirus. "While standard vaccine development timelines can take five to 20 years, we plan to submit a COVID-19 vaccine to health authorities for regulatory reviews in 2021."


Source: CBC News April 28, 2021 07:52 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */